Skip to main content
. 2018 Jul 16;48(12):1736–1744. doi: 10.1007/s00247-018-4197-6

Table 1.

Demographic comparison for patients with pleural effusion present (PE+) and without pleural effusion (PE-)

All PE- PE+ P-valuea
n 1,423 1,206 217
Age (mean ± se) 14.6±0.087 14.4±0.098 15.5±0.17 <0.0001
Gender
 Male 756 657 (54%) 99 (46%) 0.02
 Female 667 549 (46%) 118 (54%)
Stage
 I 82 79 (7%) 3 (1%) 0.0006
 II 838 686 (57%) 152 (70%)
 III 297 262 (22%) 35 (16%)
 IV 206 179 (15%) 27 (12%)
Histology (predominant)
 Lymphocyte 82 81 (7%) 1 (0.5%) <0.0001
 Lymphocyte depleted 3 2 (0.2%) 1 (0.5%)
 Nodular sclerosing 1,154 958 (79%) 196 (90%)
 Mixed cellularity 122 115 (10%) 7 (3%)
 Unknown 62 50 (4%) 12 (6%)
LMA
 No 814 766 (64%) 48 (22%) <0.0001
 Yes 554 395 (33%) 159 (73%)
 Unknown 55 45 (4%) 10 (5%)
Response
 RER 1,135 995 (83%) 140 (65%) <0.0001
 SER 264 190 (16%) 74 (34%)
 Unknown 24 21 (2%) 3 (1%)

aChi-square test performed on categorical variables and analysis of variance (ANOVA) test on continuous variables. If the P-values of the comparison are smaller than 0.05, it is considered that there are significant differences between the two groups. Any significant findings will be represented with P-values in bold font

LMA large mediastinal adenopathy, RER rapid early responders, se standard error, SER slow early responders